Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) – Not A Clear Buying Opportunity?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $4.58, with 4.06 million shares of worth about $18.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.90% during that period and on April 17, 2024 the price saw a […]
An Important Check-Up On Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $5.10, with 3.3 million shares of worth about $16.85 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -20.31% during that period and on April 11, 2024 the price saw a […]
Biocryst Pharmaceuticals Inc. (BCRX) Volatility Spurs A Quest For Clarity
Currently, there are 205.77M common shares owned by the public and among those 198.55M shares have been available to trade. However, the script later moved the day high at 5.0100, down -7.13%. The company’s stock has a 5-day price change of -4.48% and -21.70% over the past three months. BCRX shares are trading -21.70% year […]
Biocryst Pharmaceuticals Inc. (BCRX): Insights At A Glance
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $5.15, with 2.76 million shares of worth about $14.2 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -29.93% during that period and on March 27, 2024 the price saw a […]
Are Analysts Expecting A Better 2020 For Biocryst Pharmaceuticals Inc. (BCRX)?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $5.49, with 2.63 million shares of worth about $14.41 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -22.78% during that period and on March 21, 2024 the price saw a […]
Better Times Ahead For Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Thursday at a closing price of $4.89, with 4.04 million shares of worth about $19.73 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -28.92% during that period and on March 14, 2024 the price saw a […]
Look At Analyst Expectations For A Better Read On Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
Currently, there are 205.77M common shares owned by the public and among those 198.50M shares have been available to trade. Insiders at the company have transacted a total of 20 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, […]
Investors Should Take Note Of Biocryst Pharmaceuticals Inc. (BCRX)
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on Wednesday at a closing price of $5.57, with 4.17 million shares of worth about $23.21 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -19.74% during that period and on Wednesday the price saw a gain of […]
Stick With Biocryst Pharmaceuticals Inc. (BCRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
Is Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Proving The Doubters Wrong?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on 01/04/24 at a closing price of $6.46, with 3.96 million shares of worth about $25.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.18% during that period and on Thursday the price saw a gain of […]
